-
Taiwan raids tech firms in China AI chip smuggling probe
-
Online same-sex romance series embrace AI 'freedom'
-
Morocco 'unstoppable' says coach after Netherlands thriller
-
New Oxford academic centre symbolises UK's big-donor era
-
Russia's small businesses pay the price of spiralling Ukraine war
-
Trump says Iran meeting set in Qatar, despite uncertainty
-
Paraguay shock Germany as Brazil, Morocco advance at World Cup
-
Morocco down Netherlands to reach World Cup last 16
-
NASA robot mission aiming to rescue space telescope
-
Asian stocks unable to track Wall St higher, yen holds at 40-year low
-
Mouse-that-roared Paraguay savors World Cup win over Germany
-
'We came from nothing': DR Congo dreams of England World Cup upset
-
Taiwan's ageing seaweed harvesters hope younger women wade in
-
Peruvian political heir Fujimori wins presidency
-
Key Venezuela port opens with US aid, as burials begin
-
What to expect as EU small parcel levy kicks in
-
Ambitious Japan search for answers after World Cup exit
-
Nagelsmann says won't 'run away' after Germany World Cup exit
-
How NATO will try to keep Trump happy at Ankara summit
-
Paraguay coach salutes 'extraordinary' World Cup win over Germany
-
Ultra-wealthy Chinese exile in New York sentenced to 30 years for fraud
-
Japan fans stunned as Brazil end their World Cup dream
-
Years on, families bury 68 Indigenous victims of Guatemala civil war
-
'Powerhouse' Haaland leads by example at World Cup: Norway coach Solbakken
-
'Deliberate' Monaco explosion wounds Ukrainian oligarch
-
Sadness and joy as breakaway Catholic group nears schism
-
Paraguay shock Germany, Brazil advance at World Cup
-
Guardian Metal Resources PLC Announces Pilot Mountain Pre-Feasibility Study Results
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - June 30
-
Creality Printers Review Site Help Buyers Compare Creality Printers
-
Tenstorrent Sets New Performance Records, Launches TT- Ascalon S, and Expands Across Japan
-
Germany dumped out by Paraguay in seismic World Cup shock
-
'I recognized her ring': identifying Venezuela's dead in a makeshift morgue
-
More than 1,000 drones detected since start of World Cup: FBI
-
Tuchel defensive headache as England ready for DR Congo clash
-
Extreme heat warning issued for World Cup host Kansas City
-
US reopens Venezuela port as quake deaths top 1,700
-
Bloodied but unbowed: Sinner, Djokovic survive Wimbledon scares
-
Coach says Japan getting closer to World Cup glory despite defeat
-
Djokovic battles past Wu in 'challenging' Wimbledon first round
-
NBA Grizzlies deal Morant to Portland: report
-
World Bank drops climate finance targets in renewed action plan
-
Sweden ready for 'game of our lives' in France World Cup clash
-
Ancelotti says never doubted 'suffering' Brazil would score
-
MLS Chicago Fire announce signing of Poland's Lewandowski
-
Venezuela's quake-hit La Guaira port 'operational': US military
-
Tech rebound lifts Dow to record, yen hits 40-year low against dollar
-
Martinelli late show as Brazil down Japan to reach World Cup last 16
-
US Supreme Court rules on dragnet searches of cellphone location data
-
Madueke says he can be England's World Cup game-changer
US court keeps abortion drug available -- for now
A US appeals court has blocked moves to ban a widely-used abortion pill -- but imposed tough restrictions on access, in the latest round of an intensifying battle over reproductive rights.
The ruling issued late Wednesday preserves access for now to mifepristone -- used for more than half of all abortions in the United States -- but a question mark remains over its long-term availability in a case likely to go all the way to Supreme Court.
The new order limits access to women in the first seven weeks of pregnancy, down from 10; it requires in-person visits to obtain the pill -- a requirement lifted in recent years; and it blocks the medication from being sent by mail.
Wednesday's 2-1 ruling by a federal appeals court in New Orleans, Louisiana, came after a Texas judge overturned the Food and Drug Administration's (FDA) two-decades old approval of the drug last Friday.
The appellate court said its ruling would hold until the case was heard in full -- likely by the Supreme Court.
The latest standoff over women's reproductive freedom in America comes almost a year after the conservative-dominated Supreme Court overturned the landmark Roe v. Wade ruling that had enshrined the constitutional right to abortion for half a century.
- 'Commitment to women' -
US President Joe Biden has branded the Texas ruling as "out of bounds," and his spokeswoman, Karine Jean-Pierre, said Thursday the administration would continue fighting it in court.
"We believe that the law is on our side, and we will prevail," she told reporters during the president's visit to Dublin, Ireland.
"I can reassure the American people that that is our commitment to women ... to make sure that women are able to make decisions for themselves about their own body," she added.
Democrats and activists warn the Texas ruling -- issued by a judge appointed by former Republican president Donald Trump -- moves the nation one step closer to a nationwide abortion ban sought by many conservatives.
Judge Matthew Kacsmaryk's ruling came after a coalition of anti-abortion groups sued to freeze the national distribution of mifepristone.
The Texas judge, in his decision, adopted language used by abortion opponents, referring to abortion providers as "abortionists" and saying the drug was used to "kill the unborn human."
Kacsmaryk said the two-drug regimen that includes mifepristone had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.
But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective when used as indicated.
Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit access the procedure -- or ban it outright.
The two New Orleans judges who voted to tighten restrictions on access, Kurt Engelhardt and Andrew Oldham, were also both appointed by Trump.
The third, Catharina Haynes, is an appointee of former president George W. Bush.
Shortly after the initial Texas decision, a judge in Washington state ruled in a separate case that access to mifepristone must be preserved. The dueling opinions, along with the appeals, mean the issue is almost certain to end up before the Supreme Court.
H.Romero--AT